Inventor
Mark A. Murcko
Inventor
Holliston, MA, US
Overview
Patents· 46 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
C07KPeptides24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07DHeterocyclic compounds17%
C07CAcyclic or carbocyclic compounds7%
Y02ATechnologies for adaptation to climate change5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium2%
PatentTitleYear
10,934,302SHP2 phosphatase inhibitors and methods of use thereof20218,691,848'Inhibitors of caspases'20148,338,412'Inhibitors of P38'20128,314,141'Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease'20128,119,631'Inhibitors of interleukin-1β converting enzyme'20127,951,809'Inhibitors of p38'20117,790,713'Inhibitors of interleukin-1β converting enzyme'20107,772,366'Inhibitors of interleukin-1β converting enzyme'20107,608,632'Sulfonamide inhibitors of aspartyl protease'20097,388,017'Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease'20087,365,072'Inhibitors of p38'20087,358,273'Inhibitors of caspases'20087,321,063'Sulfonamide inhibitors of aspartyl protease'20087,288,624'Inhibitors of interleukin-1β converting enzyme'20077,273,885'Inhibitors of serine proteases, particularly HCV NS3-NS4A protease'20077,205,305'Inhibitors of p38'20076,974,809'Inhibitors of interleukin 1-β converting enzyme'20056,720,335'Sulfonamide inhibitors of aspartyl protease'20046,617,309'Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease'20036,573,259'Inhibitors of interleukin-1 converting enzyme'20036,531,474'Inhibitors of caspases'20036,423,840'Inhibitors of interleukin-1 converting enzyme'20026,420,522'Inhibitors of interleukin-1 converting enzyme'20026,392,046'Sulfonamide inhibitors of aspartyl protease'20026,372,778'Sulfonamide inhibitors of aspartyl protease'20026,329,365'Inhibitors of interleukin-1.beta. converting enzyme'20016,265,380'Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease'20016,258,948'Inhibitors of Interleukin-1.beta. converting enzyme'20016,204,261'Inhibitors of interleukin-1.beta. Converting enzyme inhibitors'20016,162,790'Inhibitors of interleukin-1.beta. converting enzyme'20006,127,372'Sulfonamide inhibitors of aspartyl protease'20006,103,711'Inhibitors of interleukin-1.beta. converting enzyme'20006,025,147'Inhibitors of interleukin-1 .beta. converting enzyme'20006,008,217'Inhibitors of interleukin-1.beta. converting enzyme'19996,004,957'Sulfonamide inhibitors of aspartyl protease'19995,977,137'Sulfonamide inhibitors of aspartyl protease'19995,973,111'Inhibitors of interleukin-1.beta. converting enzyme'19995,874,424'Inhibitors of interleukin-1.beta. converting enzyme'19995,856,353'Sulfonamide inhibitors of aspartyl protease'19995,847,135'Inhibitors of interleukin-1.beta. converting enzyme'19985,843,904'Inhibitors of interleukin-1.beta.converting enzyme'19985,783,701'Sulfonamide inhibitors of aspartyl protease'19985,756,466'Inhibitors of interleukin-1.beta. converting enzyme'19985,716,929'Inhibitors of interleukin-1.beta. converting enzyme'19985,656,627'Inhibitors of interleukin-1.beta. converting enzyme'19975,585,397'Sulfonamide inhibitors of aspartyl protease'1996Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1996–2014Patents assigned to VERTEX PHARMA (45)· patent assignee history
1996–2021Based in Holliston, MA, US· patent location history
2012–2014Patents assigned to MURCKO MARK A (4)· patent assignee history
2012–2014Patents assigned to BEMIS GUY W (3)· patent assignee history
2012–2014Patents assigned to WILSON KEITH P (3)· patent assignee history
2012–2014Patents assigned to LAUFFER DAVID J (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| VERTEX PHARMA | 45 | 1996–2014 |
| MURCKO MARK Aself | 4 | 2012–2014 |
| BEMIS GUY W | 3 | 2012–2014 |
| WILSON KEITH P | 3 | 2012–2014 |
| LAUFFER DAVID J | 2 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Holliston, Massachusetts, US | 46 | 1996–2021 |